Newmedica

Description

The service will provide routine elective secondary care services for patients in the following specialities • Ophthalmology • Diagnostics procedures forming part of an agreed pathway • Direct access to diagnostics procedures, where this has been specifically agreed by the Commissioner • Glaucoma Glaucoma (Remedy BNSSG ICB) Lot 1: The service will provide routine elective secondary care services for patients in the following specialities • Ophthalmology • Diagnostics procedures forming part of an agreed pathway • Direct access to diagnostics procedures, where this has been specifically agreed by the Commissioner • Glaucoma Glaucoma (Remedy BNSSG ICB) The services will include, where appropriate • Pre-treatment e.g. referral processes; triage/clinical assessment; diagnostics; consultation; pre-treatment assessment and / or work up. • Treatment e.g. outpatient/ambulatory/inpatient treatment • Discharge e.g. expected physical, self-care, psychological capabilities prior to discharge. • Follow up e.g. specialist support post discharge, referrals to other general or specialist services such as GP or District Nurse, self-care requirements for a period up to and including 14 days post discharge. The award has been made following Direct Award Process B. The procurement has been conducted in line with Right To Choose requirements. This is an activity-based contract with no guaranteed value. The contract has been awarded for the period 01/04/2026 - 31/03/2027 with no provision for extension included NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board (ICB) and Gloucestershire ICB are currently working together in a formal "clustering" arrangement to prepare for their merger into a single, new organisation (name to be confirmed), effective from 1st April 2027. This procurement notice has been issued by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners